Tau phosphorylation sites serine202 and serine396 are differently altered in chronic traumatic encephalopathy and Alzheimer's disease

Alzheimers Dement. 2022 Aug;18(8):1511-1522. doi: 10.1002/alz.12502. Epub 2021 Dec 2.

Abstract

Introduction: Chronic traumatic encephalopathy (CTE) is a neurodegenerative tauopathy associated with repetitive head impacts (RHI) typically sustained by contact sport athletes. Post-translation modifications to tau in CTE have not been well delineated or compared to Alzheimer's disease (AD).

Methods: We measured phosphorylated tau epitopes within dorsolateral frontal cortex from post mortem brains with neither CTE nor AD (n = 108), CTE (n = 109), AD (n = 223), and both CTE and AD (n = 33).

Results: Levels of hyperphosphorylated tau (p-tau)202 , p-tau231 , and p-tau396 were significantly increased in CTE. Total years of RHI exposure was significantly associated with increased p-tau202 levels (P = .001), but not p-tau396 . Instead, p-tau396 was most closely related to amyloid beta (Aβ)1-42 levels (P < .001). The p-tau202 :p-tau396 ratio was significantly increased in early and late CTE compared to AD.

Discussion: In frontal cortex, p-tau202 is the most upregulated p-tau species in CTE, while p-tau396 is most increased in AD. p-tau202 and p-tau396 measurements may aid in developing biomarkers for disease.

Keywords: Alzheimer's disease; amyloid beta peptides; brain; chronic traumatic encephalopathy; football; humans; male; microtubule-associated proteins; pathology; statistics and numerical data; tau proteins; tauopathies.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Alzheimer Disease* / complications
  • Amyloid beta-Peptides / metabolism
  • Chronic Traumatic Encephalopathy*
  • Humans
  • Phosphorylation
  • tau Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • tau Proteins